{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T10:35:21Z","timestamp":1794566121343,"version":"4.9.1"},"reference-count":30,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,2]]},"abstract":"<jats:p>Primary peritoneal malignant mesothelioma (MM) can demonstrate morphologic overlap with low-grade and high-grade tubo-ovarian serous neoplasms; it is also biologically and prognostically distinct from benign mesothelial proliferations. Currently, there is no single biomarker that can definitively distinguish these neoplasms. Sex-determining region Y box 6 (SOX6) immunohistochemistry has been recently described to differentiate pleural epithelioid MM from lung adenocarcinoma, but it has not been evaluated in the peritoneum. SOX6 immunohistochemistry was performed on 43 peritoneal epithelioid MM, 7 peritoneal biphasic MM, 5 well-differentiated papillary mesotheliomas, 5 serous borderline tumors, 29 low-grade serous carcinomas (LGSCs), 20 high-grade serous carcinomas (HGSCs), and 25 cases of peritoneal reactive mesothelial hyperplasia. Quantitative SOX6 expression in epithelioid MM (median, 100% of tumor cells) was significantly greater than in LGSC\/serous borderline tumor (median, 90%; <jats:italic toggle=\"yes\">P<\/jats:italic>=0.004) and HGSC (median, 45%; <jats:italic toggle=\"yes\">P<\/jats:italic>=0.0001). However, when SOX6 is expression is defined as \u226510% of tumor cells, there was no significant difference in the rate of SOX6 positivity between epithelioid MM (41\/43, 95%), LGSC (28\/29, 97%; <jats:italic toggle=\"yes\">P<\/jats:italic>=1.0), and HGSC (17\/20, 85%; <jats:italic toggle=\"yes\">P<\/jats:italic>=0.16). Quantitative extent of SOX6 expression in epithelioid MM was significantly greater than in biphasic MM (median, 0%; <jats:italic toggle=\"yes\">P<\/jats:italic>=0.0001), well-differentiated papillary mesothelioma (median, 20%; <jats:italic toggle=\"yes\">P<\/jats:italic>=0.001), and reactive mesothelial hyperplasia (median, 20%; <jats:italic toggle=\"yes\">P<\/jats:italic>=0.0001), but not significantly different from flat quiescent mesothelium (median, 90%; <jats:italic toggle=\"yes\">P<\/jats:italic>=0.82). SOX6 immunohistochemistry is 95% sensitive for peritoneal epithelioid MM, but is also consistently expressed in LGSC and HGSC, negating its usefulness in this common differential diagnosis. SOX6 also shows variable expression across the spectrum of reactive, benign neoplastic, and malignant mesothelial lesions of the peritoneum, and does not appear to be diagnostically useful in distinguishing benign from malignant mesothelial proliferations.<\/jats:p>","DOI":"10.1097\/pas.0000000000001792","type":"journal-article","created":{"date-parts":[[2021,8,19]],"date-time":"2021-08-19T22:25:14Z","timestamp":1629411914000},"page":"213-219","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":9,"title":["SOX6 Expression Is Sensitive for Peritoneal Epithelioid Malignant Mesothelioma, But Not Specific in the Differential Diagnosis With Tubo-ovarian Serous Neoplasia"],"prefix":"10.1097","volume":"46","author":[{"given":"David B.","family":"Chapel","sequence":"first","affiliation":[{"name":"Department of Pathology and Clinical Laboratories, University of Michigan - Michigan Medicine, Ann Arbor, MI"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle S.","family":"Hirsch","sequence":"additional","affiliation":[{"name":"Women\u2019s and Perinatal Division, Department of Pathology, Brigham and Women\u2019s Hospital and Harvard Medical School, Boston, MA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2021,8,18]]},"reference":[{"key":"R1-20250608","doi-asserted-by":"crossref","first-page":"743","DOI":"10.2147\/CLEP.S105396","article-title":"Mesothelioma in the United States: a Surveillance, Epidemiology, and End Results (SEER)-Medicare investigation of treatment patterns and overall survival","volume":"8","author":"Beebe-Dimmer","year":"2016","journal-title":"Clin Epidemiol"},{"key":"R2-20250608","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1097\/PAS.0000000000001418","article-title":"Malignant diffuse mesothelioma in women: a study of 354 cases","volume":"44","author":"Pavlisko","year":"2020","journal-title":"Am J Surg Pathol"},{"key":"R3-20250608","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.humpath.2019.07.009","article-title":"Mesothelioma of the tunica vaginalis testis","volume":"92","author":"Butnor","year":"2019","journal-title":"Hum Pathol"},{"key":"R4-20250608","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.jtho.2015.11.005","article-title":"The 2015 World Health Organization Classification of Tumors of the Pleura: advances since the 2004 Classification","volume":"11","author":"Galateau-Salle","year":"2016","journal-title":"J Thorac Oncol"},{"key":"R5-20250608","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1097\/PAS.0000000000001545","article-title":"Malignant mesothelioma of the peritoneum in women: a clinicopathologic study of 164 cases","volume":"45","author":"Malpica","year":"2021","journal-title":"Am J Surg Pathol"},{"key":"R6-20250608","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1038\/s41379-020-00688-4","article-title":"Malignant peritoneal mesothelioma: prognostic significance of clinical and pathologic parameters and validation of a nuclear-grading system in a multi-institutional series of 225 cases","volume":"34","author":"Chapel","year":"2021","journal-title":"Mod Pathol"},{"key":"R7-20250608","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1111\/his.12807","article-title":"Prognostic significance of morphological growth patterns and mitotic index of epithelioid malignant peritoneal mesothelioma","volume":"68","author":"Krasinskas","year":"2016","journal-title":"Histopathology"},{"key":"R8-20250608","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.1245\/s10434-020-08324-w","article-title":"The Chicago Consensus on Peritoneal Surface Malignancies: management of peritoneal mesothelioma","volume":"27","year":"2020","journal-title":"Ann Surg Oncol"},{"key":"R10-20250608","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.21037\/tlcr.2019.11.29","article-title":"Application of immunohistochemistry in diagnosis and management of malignant mesothelioma","volume":"9","author":"Chapel","year":"2020","journal-title":"Transl Lung Cancer Res"},{"key":"R11-20250608","doi-asserted-by":"crossref","first-page":"89","DOI":"10.5858\/arpa.2017-0124-RA","article-title":"Guidelines for pathologic diagnosis of malignant mesothelioma 2017 update of the Consensus Statement From the International Mesothelioma Interest Group","volume":"142","author":"Husain","year":"2018","journal-title":"Arch Pathol Lab Med"},{"key":"R12-20250608","doi-asserted-by":"crossref","first-page":"1692","DOI":"10.1038\/onc.2015.234","article-title":"Role of p14ARF-HDM2-p53 axis in SOX6-mediated tumor suppression","volume":"35","author":"Wang","year":"2016","journal-title":"Oncogene"},{"key":"R13-20250608","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1097\/PAS.0000000000001507","article-title":"SOX6 is a novel immunohistochemical marker for differential diagnosis of epithelioid mesothelioma from lung adenocarcinoma","volume":"44","author":"Kambara","year":"2020","journal-title":"Am J Surg Pathol"},{"key":"R14-20250608","doi-asserted-by":"crossref","DOI":"10.1097\/PAS.0000000000001712","article-title":"Utility of SOX6 and DAB2 for the diagnosis of malignant mesothelioma","author":"Naso","year":"2021","journal-title":"Am J Surg Pathol"},{"key":"R15-20250608","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1038\/s41379-018-0127-2","article-title":"Well-differentiated papillary mesothelioma of the peritoneum is genetically defined by mutually exclusive mutations in TRAF7 and CDC42","volume":"32","author":"Stevers","year":"2019","journal-title":"Mod Pathol"},{"key":"R16-20250608","doi-asserted-by":"crossref","first-page":"2269","DOI":"10.1038\/s41379-020-0588-y","article-title":"Molecular characterization of diffuse malignant peritoneal mesothelioma","volume":"33","author":"Hung","year":"2020","journal-title":"Mod Pathol"},{"key":"R17-20250608","first-page":"EC36","article-title":"Diagnostic utility of epithelial membrane antigen (EMA) and calretinin (CAL) in effusion cytology","volume":"11","author":"Nautiyal","year":"2017","journal-title":"J Clin Diagn Res"},{"key":"R18-20250608","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1097\/PAS.0b013e3182354a79","article-title":"Well-differentiated papillary mesothelioma of the female peritoneum: a clinicopathologic study of 26 cases","volume":"36","author":"Malpica","year":"2012","journal-title":"Am J Surg Pathol"},{"key":"R19-20250608","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.anndiagpath.2018.10.012","article-title":"Well-differentiated papillary mesothelioma: a 17-year single institution experience with a series of 75 cases","volume":"38","author":"Sun","year":"2019","journal-title":"Ann Diagn Pathol"},{"key":"R20-20250608","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.humpath.2017.10.036","article-title":"Aberrant Pax-8 expression in well-differentiated papillary mesothelioma and malignant mesothelioma of the peritoneum: a clinicopathologic study","volume":"72","author":"Xing","year":"2018","journal-title":"Hum Pathol"},{"key":"R21-20250608","first-page":"1010428317705508","article-title":"The role of Sox6 and Netrin-1 in ovarian cancer cell growth, invasiveness, and angiogenesis","volume":"39","author":"Li","year":"2017","journal-title":"Tumour Biol"},{"key":"R22-20250608","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.humpath.2015.12.012","article-title":"Loss of BAP1 expression is very rare in peritoneal and gynecologic serous adenocarcinomas and can be useful in the differential diagnosis with abdominal mesothelioma","volume":"51","author":"Andrici","year":"2016","journal-title":"Hum Pathol"},{"key":"R23-20250608","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1097\/00000478-199810000-00005","article-title":"Role of immunohistochemistry in distinguishing epithelial peritoneal mesotheliomas from peritoneal and ovarian serous carcinomas","volume":"22","author":"Ord\u00f3\u00f1ez","year":"1998","journal-title":"Am J Surg Pathol"},{"key":"R24-20250608","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1038\/modpathol.3800471","article-title":"The diagnostic utility of immunohistochemistry and electron microscopy in distinguishing between peritoneal mesotheliomas and serous carcinomas: a comparative study","volume":"19","author":"Ord\u00f3\u00f1ez","year":"2006","journal-title":"Mod Pathol"},{"key":"R25-20250608","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1046\/j.1365-2559.2002.01352.x","article-title":"Value of mesothelial and epithelial antibodies in distinguishing diffuse peritoneal mesothelioma in females from serous papillary carcinoma of the ovary and peritoneum","volume":"40","author":"Attanoos","year":"2002","journal-title":"Histopathology"},{"key":"R26-20250608","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1136\/jclinpath-2015-203211","article-title":"Peritoneal malignant mesothelioma (PMM), and primary peritoneal serous carcinoma (PPSC) and reactive mesothelial hyperplasia (RMH) of the peritoneum. Immunohistochemical and fluorescence in situ hybridisation (FISH) analyses","volume":"69","author":"Kawai","year":"2016","journal-title":"J Clin Pathol"},{"key":"R27-20250608","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1097\/PAS.0b013e3181da7687","article-title":"PAX8 reliably distinguishes ovarian serous tumors from malignant mesothelioma","volume":"34","author":"Laury","year":"2010","journal-title":"Am J Surg Pathol"},{"key":"R28-20250608","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1097\/PAS.0b013e318216c112","article-title":"A comprehensive analysis of PAX8 expression in human epithelial tumors","volume":"35","author":"Laury","year":"2011","journal-title":"Am J Surg Pathol"},{"key":"R29-20250608","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1097\/PAS.0000000000000935","article-title":"PAX8 expression in a subset of malignant peritoneal mesotheliomas and benign mesothelium has diagnostic implications in the differential diagnosis of ovarian serous carcinoma","volume":"41","author":"Chapel","year":"2017","journal-title":"Am J Surg Pathol"},{"key":"R30-20250608","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1016\/j.humpath.2015.03.017","article-title":"PAX8 expression in ovarian surface epithelial cells","volume":"46","author":"Adler","year":"2015","journal-title":"Hum Pathol"},{"key":"R31-20250608","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1097\/PGP.0b013e3181f45f3e","article-title":"The origin of ovarian carcinomas: a unifying hypothesis","volume":"30","author":"Auersperg","year":"2011","journal-title":"Int J Gynecol Pathol"}],"container-title":["American Journal of Surgical Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/PAS.0000000000001792","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,8]],"date-time":"2025-06-08T21:04:17Z","timestamp":1749416657000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/PAS.0000000000001792"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,18]]},"references-count":30,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.1097\/pas.0000000000001792","relation":{},"ISSN":["0147-5185"],"issn-type":[{"value":"0147-5185","type":"print"}],"subject":[],"published":{"date-parts":[[2021,8,18]]}}}